Roivant Sciences (ROIV) Amortizatization of Intangibles (2021 - 2025)

Roivant Sciences (ROIV) reported Amortizatization of Intangibles of $29.6 million for Q4 2025, down 45.48% on a YoY basis from $54.3 million in Q4 2024, and up 512.57% quarter-over-quarter from -$7.2 million in Q3 2025.

Roivant Sciences (ROIV) Amortizatization of Intangibles (2021 - 2025) Analysis & Trends

Roivant Sciences has reported Amortizatization of Intangibles for 5 years, with the latest figure at $29.6 million in Q4 2025.

  • For the quarter ending Q4 2025, Amortizatization of Intangibles fell 45.48% year-over-year to $29.6 million; the trailing twelve-month figure through Dec 2025 stood at $87.8 million (up 52.78% YoY), and the FY2026 full-year result was $8.3 million, up 20.94% from the prior year.
  • Amortizatization of Intangibles for Q4 2025 stood at $29.6 million, up from -$7.2 million in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $54.3 million in Q4 2024, with the low at -$7.2 million in Q3 2025.
  • Historically, Amortizatization of Intangibles has averaged $10.0 million across 5 years, with a median of $3.2 million in 2024.
  • Annual changes were most pronounced in 2024 — Amortizatization of Intangibles soared 86.32% — and 2025, when it tumbled 327.09%.
  • Roivant Sciences' Amortizatization of Intangibles stood at $5.4 million in 2021, then grew by 11.2% to $6.0 million in 2022, then slumped by 71.78% to $1.7 million in 2023, then jumped by 3101.89% to $54.3 million in 2024, then sank by 45.48% to $29.6 million in 2025.
  • The last three Amortizatization of Intangibles figures came in at $29.6 million (Q4 2025), -$7.2 million (Q3 2025), and $11.1 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 13,267.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Roivant Sciences 21.82 Bn 22.59 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 29.61 Mn
Dec 31, 2025 29.61 Mn
Sep 30, 2025 -7.18 Mn
Sep 30, 2025 -7.18 Mn
Jun 30, 2025 11.06 Mn
Jun 30, 2025 11.06 Mn
Dec 31, 2024 54.30 Mn
Dec 31, 2024 54.30 Mn
Sep 30, 2024 3.16 Mn
Sep 30, 2024 3.16 Mn
Sep 30, 2023 1.70 Mn
Sep 30, 2023 1.70 Mn
Jun 30, 2023 1.62 Mn
Jun 30, 2023 1.62 Mn
Dec 31, 2022 6.01 Mn
Dec 31, 2022 6.01 Mn
Sep 30, 2022 2.19 Mn
Sep 30, 2022 2.19 Mn
Jun 30, 2022 2.00 Mn
Jun 30, 2022 2.00 Mn